CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
465.31 -2.67(-0.57%) NAV as on 10 Mar 2025
-4.48 % 1 M
8.62 % 1 Y
18.26 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.82

As on 28 Feb, 2025
age-icon Age :

20 yrs 9 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

7,637.04 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.37

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2025
Others 1.11 %
Equity 98.89 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.68 %
Divi's Laboratories Ltd.9.32 %
Lupin Ltd.7.73 %
Cipla Ltd.5.90 %
Dr. Reddy's Laboratories Ltd.5.35 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs81.34
Hospital & Healthcare Services16.59
Business Support0.96
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 10-Mar-2025)250.18290.14270.59428.87465.31
Net Assets(Rs Crores) (as on 10-Mar-2025) 4260.99 4931.89 4304.46 7125.28 7637.04
Scheme Returns(%)(Absolute)77.3614.83-6.8558.247.26
B'mark Returns(%)(Absolute)NANANANANA
Category Rank32/7543/7565/7617/9020/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity465.31-2.67(-0.57%)NAV As on 11 Mar, 202505-Jun-2004Inception Date7,637.04AUM In Cr.8.62%1Y18.26%3Y24.61%5Y20.30%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity393.15-4.11(-1.03%)NAV As on 11 Mar, 202514-Jul-1999Inception Date3,312.89AUM In Cr.16.42%1Y22.32%3Y25.80%5Y16.11%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity34.890.03(0.09%)NAV As on 11 Mar, 202513-Jul-2018Inception Date4,611.47AUM In Cr.15.45%1Y21.88%3Y27.40%5Y20.62%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity27.32-0.23(-0.84%)NAV As on 11 Mar, 202528-Dec-2015Inception Date1,103.99AUM In Cr.8.84%1Y18.04%3Y23.10%5Y11.53%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors